Ishares Gen-immunology Hlth (IDNA) Technical Analysis
$30.27
Market is closed - opens 7 PM, 24 Apr 2026
Insights
- Ishares Gen-immunology Hlth is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ishares Gen-immunology Hlth stock suggests that it is a good time to sell or bad time to initiate a fresh position
- Based on analysis of the Moving Averages technical indicator, Ishares Gen-immunology Hlth stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Ishares Gen-immunology Hlth stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 60.29 | Sell |
Stochastic | 81.94, 85.43 | Sell |
Ultimate Oscillator | 52.23 | Neutral |
Stochastic Relative Strength Index | 81.02, 88.8 | Sell |
Moving Average Convergence Divergence | 0.51, 0.33 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 30.57 | Buy |
20 | 29.69 | Buy |
50 | 29.65 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 30.55 | Buy |
20 | 30.08 | Buy |
50 | 29.51 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 30.61 | Neutral |
20 | 29.89 | Neutral |
50 | 29.75 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.13 | Buy |
20 | 30.68 | Buy |
50 | 30.25 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.24 | Buy |
20 | 31.09 | Buy |
50 | 30.34 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 31.56 |
Resistance L2 | 31.36 |
Resistance L1 | 31.09 |
Pivot Point | 30.89 |
Support L1 | 30.62 |
Support L2 | 30.42 |
Support L3 | 30.15 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.